Cardiovascular disease in diabetes: role of hyperglycaemia and impact of glucose-lowering drugs
Please note that for mobiles we stream the presentation slides and audio of the speaker.
You must login to watch this lecture.
Professor Andrew Krentz examines the epidemiological and mechanistic evidence linking hyperglycaemia with cardiovascular disease. Professor Krentz reviews the impact of intensive glucose-lowering strategies on cardiovascular events, and considers recent cardiovascular outcome trials and their clinical implications.
This lecture was filmed at the 'Lipids, glucose and blood pressure in the management of cardiovascular disease: present and future' meeting at the Royal Society of Medicine in London.
Date of lecture: 8th of February 2017
Tips about RSM Videos
- This video is free to view for RSM Members, please log in before watching. There is a fee of £6.00 for Non-Members.
- This video is linked to a CPD credit. Both RSM members and non-members must login before watching the video to be able to claim a CPD credit.
- Click on the Slides tab to view all slides. You can make any slide larger by clicking on it.
- Click on the Chapters tab to view different parts of the video.